Aims: The purpose of this study was to establish whether the cell prolifera
tion index assessed by the monoclonal antibody MIB-1 would correlate with s
urvival in pleural malignant mesothelioma.
Methods and results: We studied a series of seven long-term survivors with
pleural malignant mesothelioma and a group of control cases with short-term
survival. All cases showed MIB-1 positive cells, and labelling indices wer
e expressed as percentage of cells with positive nuclear immunostaining by
randomly counting 1000 tumour cells. A statistically significant difference
was found between MIB-1 values in the long-term survival group and the con
trol cases with short-term survival.
Conclusions: Our results indicate that the differences in biological behavi
our of malignant mesothelioma in long-term and short-term survivors may be
explained in part by differences in tumour growth fraction and that prolife
ration index could represent an important prognostic parameter for this tum
our.